Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Glenmark Sets Sights On Regional Out-Licensing, Lot Riding On US Rhinitis NDA
May 31 2018
•
By
Anju Ghangurde
GLENMARK IS KEEN TO MONETIZE SOME OF ITS KEY R&D ASSETS VIA LICENSING
More from Business
More from Scrip